Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04735341 · ClinicalTrials.gov registry record
Prospective Post-market Data Collection for Ion Endoluminal System to Understand CT to Body Divergence
A clinical trial, sponsored by Intuitive Surgical.
- Completed
- Registry status
- 30
- Enrollment target
NCT04735341: Completed study, sponsored by Intuitive Surgical.
NCT04735341 is a clinical trial that has completed, run by Intuitive Surgical. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04735341 has completed, sponsored by Intuitive Surgical.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The goal of this study is to collect post-market data for the Ion Endoluminal System to understand CT to body divergence.
Primary Outcome
The collection of data relating to the Ion catheter shape
Interventions
- DEVICE Ion Endoluminal System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-12-09 |
| Est. Completion | 2022-06-30 |
What the finished NCT04735341 record still lists
NCT04735341 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ion Endoluminal System is the first listed.
NCT04735341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04735341 about?
NCT04735341 is a clinical study titled "Prospective Post-market Data Collection for Ion Endoluminal System to Understand CT to Body Divergence". The goal of this study is to collect post-market data for the Ion Endoluminal System to understand CT to body divergence.
What is the current status of trial NCT04735341?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2020-12-09. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT04735341?
The interventions under investigation include: Ion Endoluminal System (DEVICE).
Who is sponsoring clinical trial NCT04735341?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI